The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
MYC Oncogene Contributions to Release of Cell Cycle Brakes
Open accessAbstract
Promotion of the cell cycle is a major oncogenic mechanism of the oncogene c-MYC (MYC). MYC promotes the cell cycle by not only activating or inducing cyclins and CDKs but also through the downregulation or the impairment of the activity of a set of proteins that act as cell-cycle brakes. This review is focused on the role of MYC as a cell-cycle brake releaser i.e., how MYC stimulates the cell cycle mainly through the functional inactivation of cell cycle inhibitors. MYC antagonizes the activities and/or the expression levels of p15, ARF, p21, and p27. The mechanism involved differs for each protein. p15 (encoded by CDKN2B) and p21 (CDKN1A) are repressed by MYC at the transcriptional level. In contrast, MYC activates ARF, which contributes to the apoptosis induced by high MYC levels. At least in some cells types, MYC inhibits the transcription of the p27 gene (CDKN1B) but also enhances p27’s degradation through the upregulation of components of ubiquitin ligases complexes. The effect of MYC on cell-cycle brakes also opens the possibility of antitumoral therapies based on synthetic lethal interactions involving MYC and CDKs, for which a series of inhibitors are being developed and tested in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Apart from its pro-proliferative activity, RAS is known to induce cell-cycle arrest and senescence in different models of primary cells [125,126] and chronic myeloid leukemia (CML) cells [127].”
BackgroundStöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“15 a 16 are characterized for their direct interaction with CDK4 and CDK6, blocking the formation of cyclin D-CDK4/6 complexes and provoking arrested proliferation through preventing p osphorylation f RB and S-phase entry [52].”
BackgroundDang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 3×
“In agreement with previous results obtained in MEFs, Eµ-MYC derived pre-B cells showed high rates of apoptosis and increased ARF levels, while p53 levels remained constant when compared to control cells.”
BackgroundRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575 · cited 2×
“The existence of multiple MYC family members with distinct expression patterns reflects different requirements of MYC during development and in the adult animal, which is consistent with the specific way each gene is deregulated in certain cancer types [6].”
BackgroundTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Mammalian cyclin-dependent kinases
Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,295
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
Transcriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Cdk1 is sufficient to drive the mammalian cell cycle
Santamaría, D., Barrière, C., Cerqueira, A., Hunt, S., Tardy, C., Newton, K., Cáceres, J. F., Dubus, P., Malumbres, M., & Barbacid, M. (2007) · Nature · doi:10.1038/nature06046 · Cited by 1,114
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
Living with or without cyclins and cyclin-dependent kinases
Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.033 · Cited by 1,075
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“In fact, the expression of the INK4A/ARF/INK4B locus is lost in a wide range of human tumors (reviewed in [58]).”
BackgroundSherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980
Harrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A. O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1003 · Cited by 965
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
Nevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.-G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 831
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J., & Cleveland, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.20.2658 · Cited by 819
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E., Mangiola, A., Anile, C., Maira, G., Mercatelli, N., Ciafrè, S. A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601790 · Cited by 815
Tsvetkov, L. M., Yeh, K.-H., Lee, S.-J., Sun, H., & Zhang, H. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80290-5 · Cited by 791
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Self-citationMediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 739
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700
miR-221 overexpression contributes to liver tumorigenesis
Pineau, P., Volinia, S., McJunkin, K., Marchio, A., Battiston, C., Terris, B., Mazzaferro, V., Lowe, S. W., Croce, C. M., & Dejean, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907904107 · Cited by 699
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
Vlach, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5334 · Cited by 688
Seoane, J., Le, H.-V., & Massagué, J. (2002) · Nature · doi:10.1038/nature01119 · Cited by 684
Berthet, C., Aleem, E., Coppola, V., Tessarollo, L., & Kaldis, P. (2003) · Current Biology · doi:10.1016/j.cub.2003.09.024 · Cited by 663
Non-transcriptional control of DNA replication by c-Myc
Dominguez-Sola, D., Ying, C. Y., Grandori, C., Ruggiero, L., Chen, B., Li, M., Galloway, D. A., Gu, W., Gautier, J., & Dalla-Favera, R. (2007) · Nature · doi:10.1038/nature05953 · Cited by 651
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 635
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., & Pagano, M. (1999) · Genes & Development · doi:10.1101/gad.13.9.1181 · Cited by 597
Repression of p15INK4b expression by Myc through association with Miz-1
Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Möröy, T., Bartek, J., Massagué, J., Hänel, F., et al. (2001) · Nature Cell Biology · doi:10.1038/35070076 · Cited by 575
Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., Kobayashi, S. V., Lim, L., Burchard, J., Jackson, A. L., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01977-07 · Cited by 561
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells
Li, Z., Van Calcar, S., Qu, C., Cavenee, W. K., Zhang, M. Q., & Ren, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332764100 · Cited by 524
Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
Bouchard, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5321 · Cited by 502
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation
Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S., & Amati, B. (2001) · Genes & Development · doi:10.1101/gad.906601 · Cited by 499
Cyclin-dependent kinases: a family portrait
Malumbres, M., Harlow, E., Hunt, T., Hunter, T., Lahti, J. M., Manning, G., Morgan, D. O., Tsai, L.-H., & Wolgemuth, D. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1109-1275 · Cited by 495
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M., & Massagué, J. (2001) · Nature Cell Biology · doi:10.1038/35070086 · Cited by 489
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Sabò, A., Kress, T. R., Pelizzola, M., de Pretis, S., Gorski, M. M., Tesi, A., Morelli, M. J., Bora, P., Doni, M., Verrecchia, A., et al. (2014) · Nature · doi:10.1038/nature13537 · Cited by 489
Identification of CDK4 as a target of c-MYC
Hermeking, H., Rago, C., Schuhmacher, M., Li, Q., Barrett, J. F., Obaya, A. J., O'Connell, B. C., Mateyak, M. K., Tam, W., Kohlhuber, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050586197 · Cited by 471
Kim, Y.-K., Yu, J., Han, T. S., Park, S.-Y., Namkoong, B., Kim, D. H., Hur, K., Yoo, M.-W., Lee, H.-J., Yang, H.-K., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp002 · Cited by 470
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., & Land, H. (1992) · Nature · doi:10.1038/359423a0 · Cited by 460
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Genes & Development · doi:10.1101/gad.13.20.2670 · Cited by 458
Myc represses transcription through recruitment of DNA methyltransferase corepressor
Brenner, C., Deplus, R., Didelot, C., Loriot, A., Viré, E., De Smet, C., Gutierrez, A., Danovi, D., Bernard, D., Boon, T., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600509 · Cited by 445
MYC Deregulation in Primary Human Cancers
Kalkat, M., De Melo, J., Hickman, K., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W., & Penn, L. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 443
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Schaub, F. X., Dhankani, V., Berger, A. C., Trivedi, M., Richardson, A. B., Shaw, R., Zhao, W., Zhang, X., Ventura, A., Liu, Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.03.003 · Cited by 431 · cited 1×
“MYC is overexpressed by different mechanisms in 60–70% of human solid and hematopoietic tumors [1,2,3,4,5].”
BackgroundLow molecular weight inhibitors of Myc–Max interaction and function
Yin, X., Giap, C., Lazo, J. S., & Prochownik, E. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206641 · Cited by 428
Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3
Gartel, A. L., Ye, X., Goufman, E., Shianov, P., Hay, N., Najmabadi, F., & Tyner, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074898 · Cited by 417
The functional diversity of Aurora kinases: a comprehensive review
Willems, E., Dedobbeleer, M., Digregorio, M., Lombard, A., Lumapat, P. N., & Rogister, B. (2018) · Cell Division · doi:10.1186/s13008-018-0040-6 · Cited by 416
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408 · cited 1×
“The MBII is crucial for the recruitment of MYC transactivation co-activators such as TRRAP, GCN5, TIP48, TIP49, TIP60, CBP/p300, as well as SKP2 [16,17,18].”
Backgroundp21--Negative Regulator of the Cell Cycle
Gartel, A. L., Serfas, M. S., & Tyner, A. L. (1996) · Experimental Biology and Medicine · doi:10.3181/00379727-213-44046 · Cited by 407
Intrinsic Requirement for Zinc Finger Transcription Factor Gfi-1 in Neutrophil Differentiation
Hock, H., Hamblen, M. J., Rooke, H. M., Traver, D., Bronson, R. T., Cameron, S., & Orkin, S. H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00501-0 · Cited by 384
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
Horiuchi, D., Kusdra, L., Huskey, N. E., Chandriani, S., Lenburg, M. E., Gonzalez-Angulo, A. M., Creasman, K. J., Bazarov, A. V., Smyth, J. W., Davis, S. E., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111512 · Cited by 378
An alternative pathway for gene regulation by Myc
Peukert, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5672 · Cited by 364
Skp2-Mediated Degradation of p27 Regulates Progression into Mitosis
Nakayama, K., Nagahama, H., Minamishima, Y. A., Miyake, S., Ishida, N., Hatakeyama, S., Kitagawa, M., Iemura, S.-I., Natsume, T., & Nakayama, K. I. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00131-5 · Cited by 364
Regulation of the cell cycle by SCF-type ubiquitin ligases
NAKAYAMA, K., & NAKAYAMA, K. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.02.010 · Cited by 360
p53-independent functions of the p19ARF tumor suppressor
Weber, J. D., Jeffers, J. R., Rehg, J. E., Randle, D. H., Lozano, G., Roussel, M. F., Sherr, C. J., & Zambetti, G. P. (2000) · Genes & Development · doi:10.1101/gad.827300 · Cited by 354
Bouchard, C., Dittrich, O., Kiermaier, A., Dohmann, K., Menkel, A., Eilers, M., & Lüscher, B. (2001) · Genes & Development · doi:10.1101/gad.907901 · Cited by 334
Reynisdóttir, I., & Massagué, J. (1997) · Genes & Development · doi:10.1101/gad.11.4.492 · Cited by 333
Mateyak, M. K., Obaya, A. J., & Sedivy, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4672 · Cited by 331
Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27Kip1 and p21Cip1
Perez-Roger, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5310 · Cited by 329
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Goga, A., Yang, D., Tward, A. D., Morgan, D. O., & Bishop, J. M. (2007) · Nature Medicine · doi:10.1038/nm1606 · Cited by 326
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity.
Hu, Y. F., Lüscher, B., Admon, A., Mermod, N., & Tjian, R. (1990) · Genes & Development · doi:10.1101/gad.4.10.1741 · Cited by 316
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1
Karsunky, H., Zeng, H., Schmidt, T., Zevnik, B., Kluge, R., Schmid, K. W., Dührsen, U., & Möröy, T. (2002) · Nature Genetics · doi:10.1038/ng831 · Cited by 315
Li, L. H., Nerlov, C., Prendergast, G., MacGregor, D., & Ziff, E. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06724.x · Cited by 311
Shroyer, N. F., Wallis, D., Venken, K. J. T., Bellen, H. J., & Zoghbi, H. Y. (2005) · Genes & Development · doi:10.1101/gad.1353905 · Cited by 310
Structural Basis of the Cks1-Dependent Recognition of p27Kip1 by the SCFSkp2 Ubiquitin Ligase
Hao, B., Zheng, N., Schulman, B. A., Wu, G., Miller, J. J., Pagano, M., & Pavletich, N. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.003 · Cited by 301
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Soucek, L., Whitfield, J. R., Sodir, N. M., Massó-Vallés, D., Serrano, E., Karnezis, A. N., Swigart, L. B., & Evan, G. I. (2013) · Genes & Development · doi:10.1101/gad.205542.112 · Cited by 301
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro
Mermod, N., Williams, T. J., & Tjian, R. (1988) · Nature · doi:10.1038/332557a0 · Cited by 292
The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis
Carroll, P. A., Freie, B. W., Mathsyaraja, H., & Eisenman, R. N. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0650-z · Cited by 289
Max: functional domains and interaction with c-Myc.
Kato, G. J., Lee, W. M., Chen, L. L., & Dang, C. V. (1992) · Genes & Development · doi:10.1101/gad.6.1.81 · Cited by 282
Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc
Yang, W., Shen, J., Wu, M., Arsura, M., FitzGerald, M., Suldan, Z., Kim, D. W., Hofmann, C. S., Pianetti, S., Romieu-Mourez, R., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204245 · Cited by 277
Brugarolas, J., Moberg, K., Boyd, S. D., Taya, Y., Jacks, T., & Lees, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1002 · Cited by 276
Inhibition of Transcriptional Regulator Yin-Yang-1 by Association with c-Myc
Shrivastava, A., Saleque, S., Kalpana, G. V., Artandi, S., Goff, S. P., & Calame, K. (1993) · Science · doi:10.1126/science.8266081 · Cited by 274
ATP-site Directed Inhibitors of Cyclin-dependent Kinases
G ray, N., Detivaud, L., Doerig, C., & Meijer, L. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401152358 · Cited by 266
Wallis, D., Hamblen, M., Zhou, Y., Venken, K. J. T., Schumacher, A., Grimes, H. L., Zoghbi, H. Y., Orkin, S. H., & Bellen, H. J. (2003) · Development · doi:10.1242/dev.00190 · Cited by 264
Regulation of p27Kip1by miRNA 221/222 in Glioblastoma
Gillies, J. K., & Lorimer, I. A. J. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4526 · Cited by 259
Claassen, G. F., & Hann, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150006697 · Cited by 256
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
El-Deiry, W. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2055 · Cited by 256
Myc Roles in Hematopoiesis and Leukemia
Delgado, M. D., & Leon, J. (2010) · Genes & Cancer · doi:10.1177/1947601910377495 · Cited by 255
Self-citationRepression of cyclin D1: a novel function of MYC.
Philipp, A., Schneider, A., Väsrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., & Eilers, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.4032 · Cited by 251
Diosdado, B., van de Wiel, M. A., Terhaar Sive Droste, J. S., Mongera, S., Postma, C., Meijerink, W. J. H. J., Carvalho, B., & Meijer, G. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605037 · Cited by 247
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
Direct role for Myc in transcription initiation mediated by interactions with TFII-I
Roy, A. L., Carruthers, C., Gutjahr, T., & Roeder, R. G. (1993) · Nature · doi:10.1038/365359a0 · Cited by 244
den Hollander, J., Rimpi, S., Doherty, J. R., Rudelius, M., Buck, A., Hoellein, A., Kremer, M., Graf, N., Scheerer, M., Hall, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-11-251074 · Cited by 242
Functional genomics identifies therapeutic targets for MYC-driven cancer
Toyoshima, M., Howie, H. L., Imakura, M., Walsh, R. M., Annis, J. E., Chang, A. N., Frazier, J., Chau, B. N., Loboda, A., Linsley, P. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121119109 · Cited by 242
Bourne, Y., Watson, M. H., Hickey, M. J., Holmes, W., Rocque, W., Reed, S. I., & Tainer, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81065-x · Cited by 236
Feng, X.-H., Liang, Y.-Y., Liang, M., Zhai, W., & Lin, X. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00430-0 · Cited by 231
Warner, B. J., Blain, S. W., Seoane, J., & Massagué, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5913 · Cited by 230
Pérez-Roger, I., Solomon, D. L., Sewing, A., & Land, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201197 · Cited by 230
Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., & Penn, L. Z. (1994) · PubMed · Cited by 227
Design and properties of a Myc derivative that efficiently homodimerizes
Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., & Nasi, S. (1998) · Oncogene · doi:10.1038/sj.onc.1202199 · Cited by 221
Roscovitine in cancer and other diseases.
Cicenas, J., Kalyan, K. P., Sorokinas, A., Stankunas, E., Levy, J., Meskinyte, I., Stankevičius, V., Kaupinis, A., & Valius, M. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.03.61 · Cited by 219
Jiang, G., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2007) · Journal of Virology · doi:10.1128/jvi.01208-07 · Cited by 218
p19ARF directly and differentially controls the functions of c-Myc independently of p53
Qi, Y., Gregory, M. A., Li, Z., Brousal, J. P., West, K., & Hann, S. R. (2004) · Nature · doi:10.1038/nature02958 · Cited by 214
Bhadury, J., Nilsson, L. M., Veppil Muralidharan, S., Green, L. C., Li, Z., Gesner, E. M., Hansen, H. C., Keller, U. B., McLure, K. G., & Nilsson, J. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406722111 · Cited by 212
Ramírez, A., Bravo, A., Jorcano, J. L., & Vidal, M. (1994) · Differentiation · doi:10.1046/j.1432-0436.1994.5810053.x · Cited by 206
CAK—Cyclin-Dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs?
Lolli, G., & Johnson, L. N. (2005) · Cell Cycle · doi:10.4161/cc.4.4.1607 · Cited by 203
Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
Annibali, D., Whitfield, J. R., Favuzzi, E., Jauset, T., Serrano, E., Cuartas, I., Redondo-Campos, S., Folch, G., Gonzàlez-Juncà, A., Sodir, N. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5632 · Cited by 200
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
Huang, C.-H., Lujambio, A., Zuber, J., Tschaharganeh, D. F., Doran, M. G., Evans, M. J., Kitzing, T., Zhu, N., de Stanchina, E., Sawyers, C. L., et al. (2014) · Genes & Development · doi:10.1101/gad.244368.114 · Cited by 198
Skp2-dependent degradation of p27kip1 is essential for cell cycle progression
Kossatz, U., Dietrich, N., Zender, L., Buer, J., Manns, M. P., & Malek, N. P. (2004) · Genes & Development · doi:10.1101/gad.321004 · Cited by 194
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
O'Hagan, R. C., Ohh, M., David, G., de Alboran, I. M., Alt, F. W., Kaelin, W. G., & DePinho, R. A. (2000) · Genes & Development · doi:10.1101/gad.827200 · Cited by 194
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Poole, C. J., & Van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 183
Regulation of gene transcription by the oncoprotein MYC
Lüscher, B., & Vervoorts, J. (2011) · Gene · doi:10.1016/j.gene.2011.12.027 · Cited by 182
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression
Karlsson, A. E., Deb-Basu, D., Cherry, A. M., Turner, S., Ford, J. M., & Felsher, D. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732638100 · Cited by 181
Yang, D., Liu, H., Goga, A., Kim, S., Yuneva, M., & Bishop, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008366107 · Cited by 177
Contributions of Myc to tumorigenesis
Lutz, W., Leon, J., & Eilers, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00036-7 · Cited by 177
Roderick, J. E., Tesell, J., Shultz, L. D., Brehm, M. A., Greiner, D. L., Harris, M. H., Silverman, L. B., Sallan, S. E., Gutiérrez, A., Look, A. T., et al. (2014) · Blood · doi:10.1182/blood-2013-08-522698 · Cited by 176
Duan, Z., Zarebski, A., Montoya-Durango, D., Grimes, H. L., & Horwitz, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10338-10351.2005 · Cited by 172
Small-molecule inhibitors of the Myc oncoprotein
Fletcher, S., & Prochownik, E. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.005 · Cited by 167
Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W., & Eilers, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201440 · Cited by 167
Differential Modification of p27 Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity
James, M. K., Ray, A., Leznova, D., & Blain, S. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02171-06 · Cited by 165
CHEK again: Revisiting the development of CHK1 inhibitors for cancer therapy
McNeely, S., Beckmann, R., & Bence Lin, A. K. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.005 · Cited by 163
Itzhaki, J. E., Gilbert, C., & Porter, A. (1997) · Nature Genetics · doi:10.1038/ng0397-258 · Cited by 163
Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
Chen, D., Shan, J., Zhu, W.-G., Qin, J., & Gu, W. (2010) · Nature · doi:10.1038/nature08820 · Cited by 160
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis.
Soucek, L., Jucker, R., Panacchia, L., Ricordy, R., Tatò, F., & Nasi, S. (2002) · PubMed · Cited by 160
The Oscar-worthy role of Myc in apoptosis
Meyer, N., Kim, S. S., & Penn, L. Z. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.011 · Cited by 158
Nguyen, H., Gitig, D. M., & Koff, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1190 · Cited by 158
Cowling, V. H., & Cole, M. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01828-06 · Cited by 155
Transcriptional Repression of Human Immunodeficiency Virus Type 1 by AP-4
Imai, K., & Okamoto, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511773200 · Cited by 153
AP4 encodes a c-MYC-inducible repressor of p21
Jung, P., Menssen, A., Mayr, D. C., & Hermeking, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801773105 · Cited by 153
Transcriptional Repression: The Dark Side of Myc
Herkert, B., & Eilers, M. (2010) · Genes & Cancer · doi:10.1177/1947601910379012 · Cited by 150
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 149
Synergistic action of the microRNA‐17 polycistron and Myc in aggressive cancer development
Tagawa, H., Karube, K., Tsuzuki, S., Ohshima, K., & Seto, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00531.x · Cited by 148
Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
Höglund, A., Nilsson, L. M., Muralidharan, S. V., Hasvold, L. A., Merta, P. J., Rudelius, M., Nikolova, V. D., Keller, U. B., & Nilsson, J. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1198 · Cited by 146
Myc and its interactors take shape
Tu, W. B., Helander, S., Pilstål, R., Hickman, K. A., Lourenco, C., Jurišica, I., Raught, B., Wallner, B., Sunnerhagen, M., & Penn, L. Z. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.06.002 · Cited by 141
Taming of the beast: shaping Myc-dependent amplification
Wolf, E., Lin, C. Y., Eilers, M., & Levens, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.006 · Cited by 139
Inhibition of c-myc Expression Induces Apoptosis of WEHI 231 Murine B Cells
Wu, M., Arsura, M., Bellas, R. E., Fitzgerald, M. J., Lee, H., Schauer, S. L., Sherr, D. H., & Sonenshein, G. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5015 · Cited by 136
Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase
Kurland, J. F., & Tansey, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6552 · Cited by 135
MYC and Transcription ElongationPreprint
Rahl, P. B., & Young, R. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a020990 · Cited by 133
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
McKeller, R. N., Fowler, J. L., Cunningham, J. J., Warner, N., Smeyne, R. J., Zindy, F., & Skapek, S. X. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052484199 · Cited by 132
Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc
Datta, A., Nag, A., Pan, W., Hay, N., Gartel, A. L., Colamonici, O. R., Mori, Y., & Raychaudhuri, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312305200 · Cited by 131
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 131
Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion
Zhu, J., Jankovic, D. L., Grinberg, A., Guo, L., & Paul, W. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608981103 · Cited by 130
The Role of MIZ-1 in MYC-Dependent TumorigenesisPreprint
Wiese, K. E., Walz, S., von Eyß, B., Wolf, E., Athineos, D., Sansom, O. J., & Eilers, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014290 · Cited by 130
c-Myc Overexpression Uncouples DNA Replication from Mitosis
Li, Q., & Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5339 · Cited by 129
Thompson, R. H., & Eastman, A. R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12139 · Cited by 128
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 128
Guo, J., Parise, R. A., Joseph, E., Egorin, M. J., Lazo, J. S., Prochownik, E. V., & Eiseman, J. L. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0774-y · Cited by 123
Targets of the transcriptional repressor oncoprotein Gfi-1
Duan, Z., & Horwitz, M. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031694100 · Cited by 121
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis
Diolaiti, D., McFerrin, L. G., Carroll, P. A., & Eisenman, R. N. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.016 · Cited by 121
Conzen, S. D., Gottlob, K., Kandel, E., Khanduri, P., Wagner, A. J., O'Leary, M., & Hay, N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6008-6018.2000 · Cited by 120
Berns, K., Hijmans, E. M., & Bernards, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201280 · Cited by 115
Jung, P., & Hermeking, H. (2009) · Cell Cycle · doi:10.4161/cc.8.7.7949 · Cited by 113
Schmidt, T., Karsunky, H., Gau, E., Zevnik, B., Elsässer, H., & Möröy, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202191 · Cited by 112
Myc-Mediated Proliferation and Lymphomagenesis, but Not Apoptosis, Are Compromised by E2f1 Loss
Baudino, T. A., Maclean, K. H., Brennan, J. A., Parganas, E., Yang, C., Aslanian, A., Lees, J. A., Sherr, C. J., Roussel, M. F., & Cleveland, J. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00102-3 · Cited by 111
p27 Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes
Ray, A., James, M. K., Larochelle, S., Fisher, R. P., & Blain, S. W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00898-08 · Cited by 110
Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis
Keller, U. B., Old, J. B., Dorsey, F. C., Nilsson, J. A., Nilsson, L. M., Maclean, K. H., Chung, L., Yang, C., Spruck, C., Boyd, K. L., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601691 · Cited by 109
Histone Deacetylase Inhibitor Activates the p21/WAF1/Cip1 Gene Promoter through the Sp1 Sites
Sowa, Y., ORITA, T., HIRANABE‐MINAMIKAWA, S., NAKANO, K., MIZUNO, T., Nomura, H., & Sakai, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09415.x · Cited by 106
Cowling, V. H., Chandriani, S. J., Whitfield, M. L., & Cole, M. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01959-05 · Cited by 102
Bretones, G., Acosta, J. C., Caraballo, J. M., Ferrándiz, N., Gómez‐Casares, M. T., Albajar, M., Blanco, R. E., Ruiz, P. S. B., Hung, W., Albero, M. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165977 · Cited by 100
Self-citationLoss of p27Kip1 but not p21Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis
Martins, C. P., & Berns, A. J. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf364 · Cited by 99
p27Kip1 signaling: Transcriptional and post-translational regulation
Hnit, S. S. T., Xie, C., Mu, Y., Holst, J., Bensoussan, A., SOUZA, P. D., Li, Z., & Dong, Q. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.08.005 · Cited by 97
Schauer, S. L., Wang, Z., Sonenshein, G. E., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.81 · Cited by 96
c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
Robinson, K. L., Asawachaicharn, N., Galloway, D. A., & Grandori, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005951 · Cited by 96
Zörnig, M., Schmidt, T., Karsunky, H., Grzeschiczek, A., & Möröy, T. (1996) · PubMed · Cited by 96
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
Sitry-Shevah, D., Seeliger, M. A., Ko, T. K., Ganoth, D., Breward, S. E., Itzhaki, L. S., Pagano, M., & Hershko, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205254200 · Cited by 90
Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation
Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 90
Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27
García-Gutiérrez, L., Bretones, G., Molina, E., Aréchaga, I., Symonds, C. E., Acosta, J. C., Blanco, R. E., Fernández, A., Alonso, L., Siciński, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54917-1 · Cited by 89
Self-citationc-Myc, Genome Instability, and Tumorigenesis: The Devil Is in the Details
Wade, M. R., & Wahl, G. M. (2006) · Springer eBooks · doi:10.1007/3-540-32952-8_7 · Cited by 88
Obaya, Á. J., Kotenko, I., Cole, M. D., & Sedivy, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202528200 · Cited by 88
ARF Differentially Modulates Apoptosis Induced by E2F1 and Myc
Russell, J. L., Powers, J. T., Rounbehler, R. J., Rogers, P. M., Conti, C. J., & Johnson, D. G. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1360-1368.2002 · Cited by 88
Functional analysis of the N-terminal domain of the Myc oncoprotein
Oster, S. K., Mao, D. Y. L., Kennedy, J. L., & Penn, L. Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206228 · Cited by 87
Kim, M.-Y., Jeong, B. C., Lee, J. H., Kee, H. J., Kook, H. Y., Kim, N. S., Kim, Y. H., Kim, J.-K., Ahn, K. Y., & Kim, K. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601915103 · Cited by 85
Wong, P., Miranda, F., Chan, K. V., Berlato, C., Hurst, H. C., & Scibetta, A. G. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06373-11 · Cited by 85
Cited by
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Dhanasekaran, R., Deutzmann, A., Mahauad-Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 986
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Hammond, C. A., Wu, S. W., Wang, F., MacAldaz, M. E., & Eaves, C. J. (2023) · Blood · doi:10.1182/blood.2022017174 · Cited by 40
Metadata
- Authors
- García-Gutiérrez, L., Delgado, M. D., & León, J.
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2019-03-22
- Volume
- 10
- Issue
- 3
- Pages
- 244
- ISSN
- 2073-4425 (ISSN-L)
- OpenAlex
- W2941930792
- Cited by
- 255
- References
- 243
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.